New Study in Nature Medicine Shows Novel Neuroprotective Drug Candidate Meets Primary Endpoint in Patients with Mild to Moderate Alzheimer’s Disease

Posted on by

Study exemplifies how ADDF funding fuels progress of innovative science guided by the biology of aging for future of Alzheimer’s treatment. NEW YORK, May 17, 2024 /PRNewswire/ — A study published today in Nature Medicine found that a novel neuroprotective drug candidate, LM11A-31, was…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.